mSignatureDB: a database for deciphering mutational signatures in human cancers

Po-Jung Huang1,2, Ling-Ya Chiu3, Chi-Ching Lee2,4

  • 1Department of Biomedical Sciences, Chang Gung University, Taoyuan, Taiwan.

Nucleic Acids Research
|November 18, 2017
PubMed

Insights

Understanding cancer

Area of Science:

  • Genomics
  • Cancer Research
  • Bioinformatics

Background:

  • Cancer arises from somatic mutations, but the biological processes causing them are not fully understood.
  • Cancer genomes accumulate mutations during tumor development, making mutational signature analysis crucial.
  • Existing databases like COSMIC require large cohorts and bioinformatics expertise, limiting accessibility for custom analyses.

Purpose of the Study:

  • To develop a user-friendly database for analyzing mutational signatures in cancer.
  • To enable quantification of known mutational signatures in individual tumors and custom cohorts.
  • To facilitate accessible comparison of mutational signature patterns across diverse cancer projects.

Main Methods:

  • Integrated R packages and in-house scripts for mutational signature analysis.
  • Analyzed 15,780 tumors from 73 The Cancer Genome Atlas (TCGA) and International Cancer Genome Consortium (ICGC) projects.
  • Developed mSignatureDB (http://tardis.cgu.edu.tw/msignaturedb) for signature quantification at sample resolution.

Main Results:

  • mSignatureDB successfully quantified published mutational signatures across 73 cancer projects.
  • Enabled within- and between-project comparisons of mutational signature patterns.
  • Provided a unique capability for users to perform signature analysis on their own datasets.

Conclusions:

  • mSignatureDB enhances accessibility for researchers studying cancer mutational signatures.
  • The database facilitates detailed analysis of mutational processes across large cancer cohorts.
  • Offers a novel tool for quantifying mutational signatures at the individual tumor level.